PureHealth Research LLC, a US-based health and wellness company developing premium, science-backed dietary supplements, announced on Saturday that it has launched a new collection of natural GLP-1 supplements designed to support the body's own GLP-1 production, satiety signalling, and metabolic wellness.
The products have been developed with input from medical professionals and formulated with clinically studied botanicals, to help with endogenous GLP-1 production through targeted botanical compounds.
They feature nine synergistic, clinically studied ingredients for comprehensive metabolic health support.
PureHealth Research said that its natural GLP-1 supplements offer a doctor-approved, holistic approach to healthy weight management and blood sugar support already within the normal range.
Elicera Therapeutics reports complete metabolic responses in highest‑dose CARMA cohort
Johnson & Johnson reports US FDA approval of TECVAYLI plus DARZALEX FASPRO for RRMM
Thermo Fisher Scientific opens Bay Area cryo-EM Drug Discovery Center
GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care
iLoF collaborates with Bluepharma to deploy AI-powered Optomics
Akeso agrees clinical trial collaboration with INOVIO
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation
Frontage Laboratories acquires Teddy Clinical Research Laboratory in China
Allergy Therapeutics reports positive biomarker data from PROTECT trial
HUTCHMED doses first patient in global trial of ATTC candidate HMPL-A580
Ensorcell adds new senior leadership team members
Sino Biological launches 2026-2027 Northern Hemisphere influenza vaccine strain antigens
Sanaregen receives FDA clearance for retinal degeneration clinical trial
Lynk Pharmaceuticals reveals positive topline results from zemprocitinib Phase III clinical trial
ReviR Therapeutics doses first participant in First-in-Human Phase 1 clinical trial of RTX-117